Insight

Oct 10, 2024, 15:57

New ESMO Open editorial on Immunotherapy in breast cancer

ESMO Open shared a recent article by Paola Zagami on X:

“Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?”

Dario Trapani shared a post on X:

“Don’t miss the new ESMO Open editorial on Immunotherapy in breast cancer.”

Title: Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?

Authors: P. Zagami, J. Cortés, L.A. Carey and G. Curigliano.

New ESMO Open editorial on Immunotherapy in breast cancer

Source: ESMO Open/X and Dario Trapani/X

Dario Trapani is a medical oncologist at the European Institute of Oncology (IEO) and a researcher in the Department of Oncology and Hemato-oncology at the University of Milan. He previously served as a Postdoctoral Researcher at the Dana-Farber Cancer Institute and is focused on population health research.

Breast Cancer cancer Dario Trapani ESMO Open European Institute of Oncology G Curigliano immunotherapy J. Cortes L.A. Carey OncoDaily Oncology P. Zagami University of Milan

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage